FCAP Q1 2026 Earnings EPS of 130 Highlights Cost Discipline Amid Modest Operating Environment Jade Biosciences Inc JBIO Q1 2026 Earnings EPS Miss Amid Continued PreRevenue Phase RILYP Q1 2024 Earnings Negative EPS Amid Preferred Stock Challenges TSS Q1 2026 Earnings EPS Blows Past Estimates Surprise of 17027 EXR Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower ULCC Q1 2026 Earnings Narrowerthanexpected loss as cost discipline aids results